China Regenerative Medicine International Limited announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was HKD 40.980 million compared to HKD 795,000 a year ago. Net loss was HKD 7.656 million compared to HKD 15.066 million a year ago. Basic earnings per share from continuing operations was HKD 0.00129 compared to basic loss per share from continuing operations of HKD 0.01095 a year ago.